Conex Pediatric Liquid
NDC Package 54859-803-16

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Conex Pediatric (dexbrompheniramine maleate, pseudoephedrine hcl) liquids is usesTemporarily relieves nasal congestion due to the common cold, hay fever or other upper repiratory allergieshelps decongest sinus opening and sinus passagesreduces swelling of nasal passages, shrinks swollen membranes, and temporarily restores freer breathing through the nosetemporarily alleviates the following symptoms due to hay fever (allergic rhinitis)runny nosesneezingitching of the nose or throatithy and watery eyes. This formulation utilizes a liquid delivery system. Marketed by Llorens Pharmaceutical International Division, this product is identified by NDC 54859-803 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
54859-803-16
Package Description
473 mL in 1 BOTTLE
Product Code
54859-803
11-Digit Billing Format
54859080316
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
473 ML
RxNorm Crosswalk
  • RxCUI: 1299143 - dexbrompheniramine maleate 1 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution
  • RxCUI: 1299143 - dexbrompheniramine maleate 0.2 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution
  • RxCUI: 1299143 - dexbrompheniramine maleate 1 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution

Clinical Specifications

Proprietary Name
Conex Pediatric
Non-Proprietary Name
Dexbrompheniramine Maleate, Pseudoephedrine Hcl
Substance Name
Dexbrompheniramine Maleate; Pseudoephedrine Hydrochloride
Dosage Form
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
UsesTemporarily relieves nasal congestion due to the common cold, hay fever or other upper repiratory allergieshelps decongest sinus opening and sinus passagesreduces swelling of nasal passages, shrinks swollen membranes, and temporarily restores freer breathing through the nosetemporarily alleviates the following symptoms due to hay fever (allergic rhinitis)runny nosesneezingitching of the nose or throatithy and watery eyes

Regulatory & Marketing

Labeler Name
Llorens Pharmaceutical International Division
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-01-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 54859-803-16 identifies a specific commercial package of 473 ml in 1 bottle of Conex Pediatric, a human over the counter drug labeled by Llorens Pharmaceutical International Division. This product is billed per "ML" milliliter and contains an estimated amount of 473 billable units per package. This liquid is formulated for oral use and contains dexbrompheniramine maleate; pseudoephedrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Llorens Pharmaceutical International Division on December 01, 2024. The current certification is valid through December 31, 2026.

How is this Llorens Pharmaceutical International Division product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 54859080316. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 473 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
54859-803-16
11-Digit CMS (5-4-2)
54859-0803-16

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.